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Abstract 
Background: Perivascular epithelioid cell tumor (PEComa) is a rare subtype of mesenchymal origin tumor composed 
of epithelioid cells which exhibits immunohistochemical co-expressions of melanocytic markers and smooth muscle 
markers.
Case presentation: In the first case, malignant uterine PEComa with vaginal and multiple lung metastasis was misdi-
agnosed preoperatively as uterine leiomyosarcoma despite a preoperative punch biopsy and immunohistochemical 
analysis of the metastatic vaginal mass. In the second case, synchronous uterine PEComa showing benign histology 
with lymph node involvement was incidentally detected after a staging operation for ovarian cancer. Definitive diag-
nosis of uterine PEComa was achieved only after hysterectomy despite preoperative assessment with pelvic magnetic 
resonance imaging and punch biopsy of metastatic lesion.
Conclusion: The authors report two rare cases of uterine PEComa diagnosed postoperatively based on the morpho-
logic and immunohistochemical features.
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Background
Perivascular epithelioid cell tumor (PEComa) is a rare 
subtype of mesenchymal origin tumors, and is composed 
of perivascular epithelioid cells with specific histologic 
and immunohistochemical features [1]. PEComa of the 
female gynecological tract is a rare entity presenting 
with variable symptoms and different prognosis for each 
individual case. The uterus is one of the most commonly 
involved sites. Preoperative distinction may at times be 
problematic, as the symptoms of uterine PEComa are 
nonspecific and similar to those of other uterine tumors, 
and some patients may be asymptomatic.
Radiologically, uterine PEComas can be highly homo-
geneous, resembling small, benign smooth muscle 
lesions, and thus, their differential diagnosis is almost 
impossible based on imaging features alone [2]. However, 
their preoperative diagnosis may be assisted by biopsy 
and subsequent immunohistochemistry, which is nearly 
always immunoreactive for both melanocytic (HMB-45, 
melan-A, MiTF) and smooth muscle markers (SMA, 
desmin, caldesmon) [3]. Herein, the authors present two 
rare cases of uterine PEComa diagnosed postoperatively.
Case presentation
Case 1
Patient 1 is a 62-year-old woman who presented with 
intermittent vaginal bleeding for 2 weeks. Her past medi-
cal history was unremarkable. Initial findings were a het-
erogenous longitudinal uterine mass of length 4.6 cm on 
ultrasonography and a hard, whitish, 2.0-cm sized mass 
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mass was performed. Histologic and immunohistochemi-
cal findings (positive for SMA, but negative for HMB45) 
were malignant tumor, suggestive of leiomyosarcoma 
(Fig.  1a, b). Pelvic magnetic resonance imaging (MRI) 
revealed a 4.6  ×  5.5  cm sized heterogeneous enhanc-
ing mass in the uterine myometrium (Fig.  2a, b). Addi-
tionally, a 2.1 ×  1.1  cm sized indistinct, heterogeneous, 
enhancing mass was observed in the lower vagina 
(Fig. 2c, d). Subsequent chest computerized tomography 
(CT) revealed multiple pulmonary metastatic nodules. 
Consequently, the patient underwent explorative laparot-
omy and surgical staging operation (Table 1). Histologic 
examination revealed that the tumor cells were predomi-
nantly composed of epithelioid cells with eosinophilic 
Fig. 1 Microscopic findings of malignant uterine PEComa (case 1, a–d). Punch biopsy from vagina (a, b); section showing atypical epithelioid 
tumor cells with marked necrosis (a, original magnification ×100). Immunostaining was negative for HMB45 (b, ×100). Tumor mass obtained 
by hysterectomy (c, d); section revealing epithelioid tumor cells with cytologic atypia and high mitotic activity (arrow) (c, ×200). The tumor cells 
showed patchy HMB45 expression by immunostaining (d, ×200). Microscopic findings of uterine mass (case 2, e, f). The tumor showed local infiltra-
tion into adjacent uterine smooth muscle (e, original magnification ×40) and predominantly benign-looking epithelioid tumor cells (f, ×400)
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cytoplasm and showed cytologic atypia, high mitotic 
activity (4/10 HPFs), an infiltrative growth pattern, and 
necrosis. Immunohistochemistry showed patchy expres-
sions of HMB45 and SMA. Tumor cells were negative 
for PAN-CK, desmin, S-100, melan-A, EMA, and CD10 
(Fig. 1c, d). In combination of these pathological features 
and the Immunohistochemistry results, the final patho-
logic diagnosis was of malignant perivascular epithelioid 
cell tumor (PEComa). The mass from vagina displayed 
the same histologic findings. The patient was started on 
the mTOR inhibitor everolimus at 25 mg i.v. weekly. She 
is undergoing surveillance at 9 months of follow-up.
Fig. 2 Preoperative pelvic MRI findings of malignant uterine PEComa (case 1, a–d). Sagittal T2-weighted (a) and axial T2-weighted (b) images 
showed two masses with heterogeneous hyperintensity in the uterine myometrium (arrow in a) and the lower vagina (arrow in b). Axial fat-sup-
pressed contrast-enhanced T1-weighted images (c, d) showed the enhancement of the masses (arrows in c, d). Preoperative pelvic MRI findings of 
benign uterine PEComa (case 2, e, f). Axial T2-weighted (e) and fat-suppressed contrast-enhanced T1-weighted (f) images showed a well-defined, 
homogeneous submucosal uterine mass (arrows), showing signal intensity or enhancement similar to that of the myometrium. Note bilateral ovar-
ian complex cystic masses with solid enhancing portions (arrowheads)
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Case 2
Patient 2 is a 38-year-old woman who presented with an 
adnexal mass and highly elevated CA125 level (3979 U/
mL). The patient had history of tuberous sclerosis. Pel-
vic MRI revealed complex cystic masses with enhanc-
ing solid portions in both ovaries, suggestive of primary 
ovarian malignancy. MRI also showed a 1.5  ×  1.0-cm 
sized well-circumscribed, homogenous, submucosal 
uterine mass showing signal intensity or enhancement 
similar to that of the myometrium, suggestive of uterine 
leiomyoma (Fig.  2e, f ). Optimal cytoreductive surgery 
was performed. Histologic examination revealed that 
serous papillary carcinoma of the ovary with multiple 
peritoneal metastases and intrauterine mass consisted 
of predominantly epithelioid tumor cells and focal infil-
trative growth into myometrium. Epithelioid tumor cells 
showed no major cytological or nuclear pleomorphism 
and low mitotic activity (Fig.  1e, f ). Sections from peri-
aortic lymph nodes showed involvement of PEComa. 
Immunohistochemistry revealed that tumor cells were 
positive for HMB45 and SMA, but negative for PAN-
CK, desmin, S-100, melan-A, EMA, c-kit, and CD10. 
These morphologic features and the immunohistochemi-
cal staining pattern confirmed a diagnosis of PEComa 
showing benign histology with involvement of peri-aortic 
lymph nodes. After surgery, the patient completed six 
cycles of adjuvant chemotherapy (paclitaxel and carbo-
platin) for ovarian cancer and was followed up regularly. 
She had no evidence of disease 8 months after treatment 
completion.
These morphologic features and the immunohis-
tochemical staining pattern confirmed a diagnosis of 
PEComa.
Discussion
Perivascular epithelioid cell tumor (PEComa) is recently 
described entity in the gynecological tract. It occurs 
most commonly in the retroperitoneum, abdominopelvic 
region, and uterus. To date, around 78 case reports have 
been issued on uterine PEComas and the most com-mon 
site in the female genital tract. We present two cases of 
PEComa of the uterus with different clinicopathological 
features (Table 1).
Clinical, radiological, and preoperative pathological 
features of PEComa cases are diagnostic challenge. In 
most of the PEComa cases, the diagnosis was confirmed 
after hysterectomy for a presumed benign disease. The 
proper preoperative diagnosis of uterine PEComa is dif-
ficult because of the lack of a reliable method to distin-
guish uterine PEComa from benign leiomyomas and 
uterine sarcoma preoperatively in addition to the rarity 
of such cases. Clinical manifestations are not useful to 
distinguish between uterine PEComas and other uterine 
tumors, since most of the patients with uterine PEComas 
show abnormal uterine bleeding or lower abdominal pain 
with a palpable mass, which is similar to the symptoms 
Table 1 Summary of clinicopathologic characteristics of the two cases of uterine PEComa
PEComas perivascular epithelioid tumors, TSC tuberous sclerosis complex, MRI magnetic resonance imaging, HPF high power field, IHC immunohistochemical, HMB-
45 human melanoma black 45, SMA smooth muscle actin, PAN-CK pan-cytokeratin, EMA epithelial membrane antigen, BSO bilateral salpingo-oophorectomy, CTX 
chemotherapy, AWD alive with disease, ANED alive with no evidence of disease
Characteristics Case 1 (uterine PEComa, malignant) Case 2 (uterine PEComa, benign)
Age (year) 62 38
Association of TSC No Yes
Synchronous cancer No Yes (epithelial ovarian cancer)
Initial presentation Abnormal uterine bleeding No
Tumor site/size (cm) Myometrial mass in uterus/4.6 cm; anterior mass in vaginal 
wall/1.2 cm
Submucosal mass in uterus/4.6 cm
Extent of disease Involvement of both lung as well as anterior vagina Involvement of peri-aortic lymph nodes
Radiologic findings (MRI) Degenerative fibroid or leiomyosarcoma Leiomyoma
Histologic findings Epithelioid; infiltrative; tumor necrosis present; cytologic 
atypia present; high mitotic activity (4/10HPFs)
Epithelioid; focal Infiltrative; major cytological or nuclear 
pleomorphism absent; low mitotic rate;
 Positive IHC profile HMB-45, SMA HMB-45, SMA
 Negative IHC profile PAN-CK, desmin, S-100, melan-A, EMA, CD10 PAN-CK, desmin, S-100, melan-A, EMA, CD10, c-kit
Treatment
 Surgical Hysterectomy; BSO; partial omentectomy; appendectomy; 
mass resection in the anterior vagina
Hysterectomy; BSO; infracolic omentectomy; pelvic LN dis-
section; para-aortic LN dissection; appendectomy
 Adjuvant mTOR inhibitor—everolimus (weekly, ongoing) Paclitaxel and carboplatin CTX (6 cycles of tri-weekly)
Follow-up Lung and bone metastases, AWD at 18 months ANED at 6 months
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and signs of other uterine tumors. PEComa can be asso-
ciated with tuberous sclerosis complex (TSC). Some 
PEComas occur in TSC patients in sites, such as, kidney, 
liver, and lung. However, uterine PEComa associated 
with tuberous sclerosis is very rare.
Imaging features of PEComas are nonspecific and 
mimic other benign and malignant neoplasms. One study 
by Tan et al. [4] reported the largest imaging series of 36 
patients with malignant PEComas. Ultrasound showed 
a heterogeneous echotexture with no cystic areas or sig-
nificant vascularity on Doppler examination. By a com-
parison with skeletal muscle, CT scans revealed a rather 
well-defined hypo- or isointense structure, and MRI also 
displayed a hypo- to isointense structure on T1-weighted 
imaging and a heterogeneously hyperintense structure 
on T2-weighted imaging. In general, the characteristics 
of contrast-enhanced CT or MRI of malignant PEComas 
were very variable, but their results showed significant 
enhancement on CT and MRI [2]. Despite such radio-
logic features, the differential diagnosis of these diseases 
from other uterine tumors is almost impossible based on 
imaging features alone. In our two cases, we performed 
imaging with MRI but failed to distinguish between uter-
ine PEComas and other uterine tumors. One of these 
two tumors was diagnosed as a degenerative fibroid or 
leiomyosarcoma because of the large tumor size and the 
presence of necrotic areas. The other was diagnosed as 
leiomyoma because of the homogeneous enhancement 
(Fig. 2a, b). MRI did not provide a definitive diagnosis in 
our cases.
Since PEComas are nearly always immunoreactive 
for both melanocytic (HMB-45, melan-A, MiTF) and 
smooth muscle (actin, desmin, caldesmon) markers, 
characteristic histologic and immunohistochemical find-
ings provide the most accurate means of diagnosis [3]. 
Preoperatively, biopsy is not usually performed in uterine 
tumors, and it is very limited in many cases. In our case 
1, we failed to differentiate uterine PEComa and leiomyo-
sarcoma despite a preoperative punch biopsy and immu-
nohistochemical analysis of the metastatic vaginal mass. 
Preoperative diagnosis was malignant tumor suggestive 
of leiomyosarcoma, mainly based on the immunohis-
tochemical results (positive for SMA, but negative for 
HMB45). However, the final immunohistochemical result 
showed patchy expression for HMB45. Therefore, it was 
finally diagnosed as malignant PEComa in conjunction 
with histologic and immunohistochemical findings. To 
prevent diagnostic error, multiple pieces of biopsy should 
be sampled in case of metastatic disease. However, mor-
phology- and immunohistochemistry-based diagnosis 
may lead to incorrect or inconclusive diagnoses due to 
patchy expression of HMB45 in tumor cells and a marked 
necrotic background [5].
Although uterine PEComas represent a spectrum of 
histologies ranging from benign to malignant lesions, 
the tumor aggressiveness has not yet been fully 
explained. Malignant uterine PEComas can spread to 
the vagina, fallopian tubes, ovaries, bladder, and ure-
ters. Distant metastasis to the lungs or liver has also 
been reported. Up to 20% of women with malignant 
uterine PEComa have an additional uterine disease at 
presentation [2]. Folpe et  al. reported that PEComas 
are divided into benign, uncertain malignant poten-
tial (UMP), or malignant tumors according to the fol-
lowing six risk factors: tumor size ≥5  cm, infiltrative 
growth pattern, high nuclear grade cellularity, mitotic 
rate >1/50 high power fields (HPF), necrosis or vascu-
lar invasion [3]. Schoolmeister et  al. revised the clas-
sification of PEComas. The tumor is considered as 
malignant when there are more than four unfavorable 
prognostic indicators (size ≥5 cm, mitoses ≥1/50 HPF, 
significant nuclear atypia, necrosis, and lymphovascu-
lar invasion) [6]. Bleeker et  al. suggested revised risk 
stratification criteria utilizing only size  ≥5  cm and 
high mitotic rate, which were the only high-risk histo-
pathologic features significantly associated with recur-
rence [7].
The most adequate management of gynecological 
PEComas has not been well established owing to the 
paucity of the cases. Surgical resection remains the treat-
ment of choice. The vast majority of patients received a 
total hysterectomy with or without bilateral salpingo-
oophorectomy. Radical hysterectomy with bilateral sal-
pingo-oophorectomy should be considered in patients 
with PEComas spreading or localized in the uterine cer-
vix [8].
Conclusion
In conclusion, we describe two rare cases of uterine 
PEComa with different clinicopathological features. 
Definitive diagnosis was achieved only after hysterec-
tomy by immunohistochemical analysis. Careful analy-
sis of morphologic and immunohistochemical features 
is necessary for an adequate differential diagnosis from 
other mesenchymal tumors. Based on our experience of 
these cases, PEComa should be considered when a uter-
ine tumor is detected despite its rarity.
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